Demand for ARF Bio's public offering came in nearly 4 times.

ARF Bio's initial public offering (IPO) on December 25-26, which reached 916.5 million lira with a fixed price of 19.50 lira per share, received 3.8 times the demand. Each individual investor was allocated an average of 47 shares. The company will start trading on Borsa Istanbul under the code ARFYE with the bell ceremony on January 5. The IPO proceeds will be used to improve operational volume and establish a microalgae facility. ARF Bio, which has attracted attention with its new generation green transformation vision, successfully completed the demand collection process for its IPO on December 25-26 at a fixed price of 19.50 TL per share. According to the announcement made to the Public Disclosure Platform (KAP), a total of 47 million TL nominal value shares were sold in the IPO, with a total IPO size of 916.5 million TL. In the IPO, 50% of the shares offered were allocated to domestic individual investors, while the remaining 50% were allocated to domestic institutional ...